Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (55 ops.)
Latest filing published 24 Sept 2026 for 10x Genomics, Inc., €68k. Read the official filing
Filing timeline
BuySaleSerge Saxonov
Insider track record
Disclosed buys
0
Disclosed sells
55
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Serge Saxonov: trading record in brief
Serge Saxonov, listed as chief executive, appears in our data through filings on 10x Genomics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 19 March 2021 to 22 September 2026, the count stands at 92 filings.
On the market, this insider has only sold: 55 sales, €7.7M in total. The totals exclude 4 filings filed without an amount. Other entries cover 6 share grants and 16 option exercises. 2026 to date brings no purchases and 19 sales.
The newest entry dates from 24 September 2026: an open-market sale of €139k, in 10x Genomics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Serge Saxonov
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations92 total
1,000 shares@ US$78.2284Class A Common StockSEC:0001610717-26-000421:0
2,000 shares@ US$79.6195Class A Common StockSEC:0001610717-26-000421:1
9,300 shares@ US$80.9033Class A Common StockSEC:0001610717-26-000421:2
9,900 shares@ US$81.8254Class A Common StockSEC:0001610717-26-000421:3
2,800 shares@ US$82.365Class A Common StockSEC:0001610717-26-000421:4
100 shares0Class A Common StockSEC:0001610717-26-000396:0
3,500 shares@ US$63.02290.0026% mcap2.5% of flowClass A Common StockSEC:0001610717-26-000393:0
6,494 shares@ US$63.97680.0049% mcap4.8% of flowClass A Common StockSEC:0001610717-26-000393:1
492 shares@ US$64.74650.0004% mcap0.4% of flowClass A Common StockSEC:0001610717-26-000393:2
18,545 shares@ US$63.02370.014% mcap14.5% of flowClass A Common StockSEC:0001610717-26-000392:0
4,000 shares0Class A Common StockSEC:0001610717-26-000386:0
8,527 sharesClass A Common StockSEC:0001610717-26-000293:0
9,991 sharesClass A Common StockSEC:0001610717-26-000293:1
9,821 sharesClass A Common StockSEC:0001610717-26-000293:2
1,661 sharesClass A Common StockSEC:0001610717-26-000293:3
18,175 shares@ US$24.44150.0059% mcap8.4% of flowClass A Common StockSEC:0001610717-26-000164:0
10,718 shares@ US$24.70920.0035% mcap5.0% of flowClass A Common StockSEC:0001610717-26-000164:1
5,000 shares@ US$24.55680.0016% mcap2.2% of flowClass A Common StockSEC:0001610717-26-000145:0
10,000 shares@ US$19.12973.8% of flowClass A Common StockSEC:0001610717-26-000134:0
14,292 shares@ US$22.6695.6% of flowClass A Common StockSEC:0001610717-26-000086:0
157,895 shares0Class A Common StockSEC:0001610717-26-000077:0
9,632 shares@ US$18.57643.1% of flowClass A Common StockSEC:0001610717-26-000070:0
50,000 shares@ US$1.201.1% of flowClass A Common StockSEC:0001610717-26-000003:0
13,261 shares@ US$18.99834.8% of flowClass A Common StockSEC:0001610717-25-000398:0
900 shares0Class A Common StockSEC:0001610717-25-000341:0
25 of 92 declarations
